CCL stock price
Since 2020, all kinds of speculation and hype surrounding the two giants in tCCL stock pricehe securities industry have not stopped. With the spread and clarification of merger rumors, the stock prices and performance of the two leading brokerage firms have been rising, which is welcome to investors anyway.
Goldman Sachs economist Andrew Boak and others said in a research report that the Reserve Bank of Australia is expected to cut interest rates by 25 basis points at policy meetings starting in March, and said that they will not rule out a 50 basis point cut on Tuesday, which will increase Australia’s economic growth in 2020. The forecast is lowered by 80 basis points to 3%.
From the perspective of capital inflows, data shows that as of the close of September 2nd, the cumulative net inflow of northbound capital this year is 1.190.1 billion yuan. Guosheng Securities’ strategy team stated that this year, despite the shrinking market risk appetite, the net inflow of northbound funds has exceeded 100 billion yuan. Taking into account that the global epidemic is expected to be gradually brought under control in the second half of the year and external disturbances are reduced, it is expected that northbound funds will maintain a return trend.
The three major A-share stock indexes surged across the board today. The Shanghai Composite Index rose 10% to close at 28,810 points; the Shenzhen Component Index rose 96% to close at 93,297 points; the ChiNext Index rose 50% to close at 16,284 points. The total turnover of the two cities was 581.6 billion yuan. The industry sector closed up almost across the board. The brokerage sector led the rise. The sector lifted a daily limit wave. Only the gold sector bucked the market and weakened. A substantial net inflow of northbound funds today was 88.3 billion yuan. (Click to view>>Shanghai-Shenzhen-Hong Kong Stock Connect Capital Flow)
From the perspective of individual stocks, during the trading days when the financing customers increased their positions on April 14-16, Choice data showed that the financing customers had a strong interest in CITIC Construction Investment, Sinopharm, CITIC Securities, Muyuan, Fosun Pharma, Huatian Technology , WuXi AppTec, Ziguang Guowei, Shenzhou Taiyue, and Tiantan Biological's increased warehouse amount are the first, the increased warehouse amount is 7.4 billion yuan, 4.2 billion yuan, 1.6 billion yuan, 1.1 billion yuan, 9.2 billion yuan, and 9.2 billion yuan. , 6.7 billion yuan, 6.6 billion yuan, 6.4 billion yuan, and 5.8 billion yuan. It can be seen that among the top stocks, pharmaceutical and biological stocks account for the majority of stocks by financing customers, and pharmaceutical and biological stocks are significantly favored by financing customers.
The difference is that the current market style is unlikely to undergo a systematic switch. Although the current financial cycle and other low-valuation sectors are all available for restoration, the economic recovery is still insufficient. Insufficient demand is the core contradiction. It is difficult for the market style to switch systematically, and it is difficult for the procyclical sector to start a systematic market. In a systemic bull market, the rising order of each sector will not be exactly the same, and it will be affected by the current eCCL stock pricenvironment and the market. History will never be repeated simply. Investors can't copy the rules of a certain bull market and follow the picture. Otherwise, the severe ones will eat meat in turn; the tragic ones will be cut repeatedly.